ST2 in emergency department patients with noncardiac dyspnea

Academic Emergency Medicine

Volumn 20, Issue 11, 2013, Pages 1207-1210

  Benoit, Justin L ^a   Hicks, Caitlin W ^b   Engineer, Rakesh S ^c   Hart, Kimberly W ^a   Lindsell, Christopher J ^a   Peacock, William F ^d  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR; PROTEIN ST2; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; ASTHMA; BLOOD LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; DYSPNEA; EMERGENCY WARD; FEMALE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FAMILY; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; ASTHMA; BIOLOGICAL MARKERS; DYSPNEA; ELECTROCARDIOGRAPHY; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT ADMISSION; PATIENT READMISSION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, CELL SURFACE; TREATMENT OUTCOME;

EID: 84888048921     PISSN: 10696563     EISSN: 15532712     Source Type: Journal    
DOI: 10.1111/acem.12250     Document Type: Article

References (10)

1. Yanagisawa K, Takagi T, Tsukamoto T, Tetsuka T, Tominaga S,. Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1. FEBS Lett. 1993; 318: 83-7.
2. Sanada S, Hakuno D, Higgins LJ, Schreiter ER, McKenzie AN, Lee RT,. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest. 2007; 117: 1538-49.
3. Weinberg EO, Shimpo M, De Keulenaer GW, et al. Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation. 2002; 106: 2961-6.
4. Weinberg EO, Shimpo M, Hurwitz S, Tominaga S, Rouleau JL, Lee RT,. Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation. 2003; 107: 721-6.
5. Januzzi JL Jr, Peacock WF, Maisel AS, et al. Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study. J Am Coll Cardiol. 2007; 50: 607-13.
6. Brown AM, Wu AH, Clopton P, Robey JL, Hollander JE,. ST2 in emergency department chest pain patients with potential acute coronary syndromes. Ann Emerg Med. 2007; 50: 153-8.
7. Martinez-Rumayor A, Camargo CA Jr, Green SM, Baggish AL, O'Donoghue M, Januzzi JL,. Soluble ST2 plasma concentrations predict 1-year mortality in acutely dyspneic emergency department patients with pulmonary disease. Am J Clin Pathol. 2008; 130: 578-84.
8. Oshikawa K, Kuroiwa K, Tago K, et al. Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am J Respir Crit Care Med. 2001; 164: 277-81.
9. Sabatine MS, Morrow DA, Higgins LJ, et al. Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction. Circulation. 2008; 117: 1936-44.
10. Dieplinger B, Januzzi JL Jr, Steinmair M, et al. Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma-the Presage ST2 assay. Clin Chim Acta. 2009; 409: 33-40.